Schedule 13G/A

Raw Filing Contents

0000315066-17-002683.txt : 20170815
0000315066-17-002683.hdr.sgml : 20170815
20170815111042
ACCESSION NUMBER:		0000315066-17-002683
CONFORMED SUBMISSION TYPE:	SC 13G/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20170815
DATE AS OF CHANGE:		20170815

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Aclaris Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001557746
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				460571712
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13G/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-89137
		FILM NUMBER:		171032870

	BUSINESS ADDRESS:	
		STREET 1:		SUITE 400, 101 LINDENWOOD DRIVE
		CITY:			MALVERN
		STATE:			PA
		ZIP:			19355
		BUSINESS PHONE:		484-321-5554

	MAIL ADDRESS:	
		STREET 1:		SUITE 400, 101 LINDENWOOD DRIVE
		CITY:			MALVERN
		STATE:			PA
		ZIP:			19355

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			FMR LLC
		CENTRAL INDEX KEY:			0000315066
		STANDARD INDUSTRIAL CLASSIFICATION:	UNKNOWN SIC - 0000 [0000]
		IRS NUMBER:				043532603
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13G/A

	BUSINESS ADDRESS:	
		STREET 1:		245 SUMMER STREET
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02210
		BUSINESS PHONE:		6175706339

	MAIL ADDRESS:	
		STREET 1:		245 SUMMER STREET
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02210

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	FMR CORP
		DATE OF NAME CHANGE:	19920717


SC 13G/A
1
filing.txt

SCHEDULE 13G

Amendment No. 3
ACLARIS THERAPEUTICS INC
COMMON STOCK
Cusip #00461U105
Check the appropriate box to designate the rule pursuant to which this
Schedule is filed:
[ ] 	  Rule 13d-1(b)
[x] 	  Rule 13d-1(c)
[ ] 	  Rule 13d-1(d)
Cusip #00461U105
Item 1: 	   	Reporting Person - FMR LLC
Item 2: 	   	(a)  	[ ]
   	   	(b)  	[ ]
Item 4: 	   	Delaware
Item 5: 	   	1,000,018
Item 6: 	   	0
Item 7: 	   	3,114,457
Item 8: 	   	0
Item 9: 	   	3,114,457
Item 11: 	   	10.382%
Item 12: 	   	HC
Cusip #00461U105
Item 1: 	   	Reporting Person - Abigail P. Johnson
Item 2: 	   	(a)  	[ ]
   	   	(b)  	[ ]
Item 4: 	   	United States of America
Item 5: 	   	0
Item 6: 	   	0
Item 7: 	   	3,114,457
Item 8: 	   	0
Item 9: 	   	3,114,457
Item 11: 	   	10.382%
Item 12: 	   	IN

Item 1(a). 	    	Name of Issuer:

  	  	          	ACLARIS THERAPEUTICS INC

Item 1(b). 	    	Address of Issuer's Principal Executive Offices:

  	  	          	Suite 400...